Lyka Labs surges as its arm plans to sell animal healthcare division to Alivira

28 Aug 2015 Evaluate

Lyka Labs is currently trading at Rs. 81.50, up by 5.05 points or 6.61% from its previous closing of Rs. 76.45 on the BSE.

The scrip opened at Rs. 77.20 and has touched a high and low of Rs. 82.90 and Rs. 77.20 respectively. So far 15,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 95.00 on 31-Jul-2015 and a 52 week low of Rs. 13.20 on 10-Sep-2014.

Last one week high and low of the scrip stood at Rs. 82.90 and Rs. 63.95 respectively. The current market cap of the company is Rs. 173.00 crore.

The promoters holding in the company stood at 23.30% while Institutions and Non-Institutions held 0.63% and 76.08% respectively.

Lyka Labs’ subsidiary Lyka Exports will sell its animal healthcare division to Alivira Animal Health, a subsidiary of Sequent Scientific, subject to approval by the shareholders of respective companies i.e. Lyka Labs and Lyka Exports. The board of directors at their meeting held on August 27, 2015 has approved for the same.

The company has convened an Extra Ordinary General Meeting of members of the company on September 29, 2015 to seek their approval to the proposed sale of Animal Healthcare Division by Lyka Exports.

Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.


Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×